Timeline

Isabelle Staropoli
Research Engineer
24 Jan 2023
17 Nov 2022
publication
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies.
Read more05 Oct 2022
publication
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.
Read more01 Sep 2022
publication
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.
Read more04 Jul 2022
publication
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Read more17 Jun 2022
news
New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Read more23 Mar 2022
publication
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies.
Read more12 Mar 2022
publication
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.
Read more01 Feb 2022
26 Jan 2022
publication
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry.
Read more01 Nov 2021
publication
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study.
Read more18 Aug 2021
01 Aug 2021
publication
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.
Read more08 Jul 2021
18 May 2021
publication
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
Read more01 Apr 2021
publication
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020.
Read more01 Jan 2021
02 Sep 2020
publication
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Read more01 Sep 2020
publication
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.
Read more06 Dec 2018
22 Nov 2016
publication
Guidelines for cloning, expression, purification and functional characterization of primary HIV-1 envelope glycoproteins
Read more16 Jul 2015
03 Jul 2015
18 Jun 2015
publication
A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity
Read more22 May 2014
publication
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry
Read more21 May 2013
publication
HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines
Read more26 Jan 2012
30 Nov 2010
publication
New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection
Read more02 Jul 2008
publication
The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins
Read more01 Jan 2007
01 Mar 2006
publication
Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells
Read more01 May 2005
publication
Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E
Read more26 Apr 2005
publication
Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals
Read more10 Mar 2005
publication
Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis
Read more27 Feb 2003
publication
DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2
Read more22 Nov 2002
publication
Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells
Read more12 Nov 2002
publication
HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains
Read more26 Feb 2002
publication
Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4
Read more10 Nov 2000
publication
Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate
Read more01 Dec 1997
publication
Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice
Read more01 Feb 1996
publication
Dengue virus envelope glycoprotein can be secreted from insect cells as a fusion with the maltose-binding protein
Read more01 Jul 1994
publication